Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Atomoxetine and Oros-mph on Executive Functions in Patients With Combined Type Attention Deficit Hyperactivity Disorder

NCT02352051 is registered in ClinicalTrials.gov with TC Erciyes University as lead sponsor.

NCT NCT02352051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02352051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Atomoxetine and Oros-mph on Executive Functions in Patients With Combined Type Attention Deficit Hyperactivity Disorder
Lead sponsor
TC Erciyes University
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2014
Completion date
October 31, 2014
Enrollment
43 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

executive dysfunction